Tag Archives: China

Tasty Asian Acquisition for Publicis

Publicis Healthcare Gobbles Up Another Asian Agency Publicis continues its expansion into Asia with today’s (Feb 20) announcement of its acquisition of U-Link Business Solutions (UBS), one of China’s leading agencies specializing in healthcare communications. As a part of Publicis Healthcare Communications Group, the agency will be renamed UBS Saatchi & Saatchi Health. “The Chinese […]
Posted in Agency Insight, Emerging Markets, Global, Guest Blog | Also tagged , , , | Leave a comment

California Life Sciences to Partner with China

BIOCOM, a trade group representing Southern California’s life sciences industry, is ramping up partnership efforts in China to meet an emerging desire for novel drug therapies. While intellectual property (IP) protections and the Chinese government’s willingness to pay for expensive new products represent two large and lingering question marks, Joe Panetta, president and CEO at […]
Posted in Biotech, Emerging Markets, Global, IP, leadership, Market Access, R&D | Also tagged , , , | Leave a comment

New Decade, New Agenda for Pharma

A new track for nonprofits, product diversification and the rise of the emerging markets —  Audrey S. Erbes reports on some of the takeaways from this week’s JP Morgan Healthcare Conference. There were some surprising changes in the format of the 29th Annual JP Morgan Healthcare Conference, the world’s premier health care industry investment meeting […]
Posted in Emerging Markets, Guest Blog, R&D | Also tagged , , , , | Leave a comment

Fixing Biotech's Broken Business Model

Despite some notable successes, the global biotech industry has fallen short of expectations. Strategic collaborations have been on the increase, but there is now a need for more co-operation using new collaboration models, writes Jo Pisani. The current business model on which biotech has relied is flawed. Due to poor rates of return, investment has […]
Posted in Biotech, Deals, Emerging Markets, Europe, Global, Guest Blog, R&D | Also tagged , , , , , , , | Leave a comment

Drug Payment Reform in China: Now That's a Mass Market

The task of building drug access for one billion new customers in China is probably this decade’s grandest public policy experiment.  It is taking place largely behind the scene in a series of often tense exchanges between Beijing and local governments – the dialogue is worth watching for the long-term commercial implications in what all […]
Posted in Emerging Markets, Global, Strategy | Also tagged , , | Leave a comment
  • Categories

  • Meta